FDA declines to review Moderna's mRNA flu shot
bikenaga Tuesday, February 10, 2026
Summary
The FDA has declined to review Moderna's mRNA-based flu shot, citing the need for additional data to support its approval. This decision delays the potential introduction of a new influenza vaccine technology to the market.
3
0
Summary
nbcnews.com